Charles K. Brown

Surgical Oncology
5201 Willow Springs Rd Ste 290
La Grange Highlands, IL 60525

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Multicenter, phase II study of axitinib, a selective second-generation inhibitor of vascular endothelial growth factor receptors 1, 2, and 3, in patients with metastatic melanoma.

Multicenter, phase II study of axitinib, a selective second-generation inhibitor of vascular endothelial growth factor receptors 1, 2, and 3, in patients with metastatic melanoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 07, 2011
Showing 1-1 of 1

Last Updated: 09/26/2026